United-Guardian, Inc. UG
Company Overview
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Why Investors Should Care
Generates a return on equity of 18.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 19.6%.
Trades at a P/E of 13.2, below the sector median of 18.7.
Maintains a net profit margin of 22.0%.
Offers a dividend yield of 7.88%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $10.55M (-13.4% YoY); net profit $2.11M.
- Trailing 12 Months Year-on-year growth — revenue +9.5%, earnings +16.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -1.7%, profit CAGR -3.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -1.74% |
| 1 Year: | 9.50% |
Compounded Profit Growth
| 5 Years: | -3.86% |
| 1 Year: | 16.20% |
Stock Price Performance
| 1 Year: | -5.12% |
| 6 Months: | +16.96% |
| 3 Months: | +5.28% |
| 1 Month: | -1.80% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)47.61 · Neutral
P/E of 13.17 is below the sector median of 18.74 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 22.0%.
- Attractive dividend yield of 7.88%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -1.7% CAGR over 5 years.
- Earnings shrank at -3.9% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UG United-Guardian, Inc. | 7.11 | 13.17 | $32.67M | 7.88% | 19.61% | 18.75% | -1.74% | -3.86% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 37.73 | $852.63B | 0.88% | 16.83% | 24.13% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 915.74 | 46.16 | $406.11B | 0.62% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.07 | 26.45 | $378.93B | 2.44% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 146.44 | 22.32 | $341.00B | 2.96% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 182.53 | 25.07 | $284.49B | 3.13% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 137.63 | 18.04 | $188.00B | 4.28% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 80.35 | 17.32 | $140.40B | 1.61% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | MO Altria Group, Inc. SPXR3K | 68.88 | 14.50 | $115.01B | 6.26% | 38.27% | - | 1.24% | -1.89% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.95M | 3.63M | 3.40M | 3.96M | 2.98M | 2.52M | 4.37M | 4.12M | 3.62M | 2.26M | 2.14M | 3.46M | 2.79M | 3.77M | 3.18M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 1.98M | 1.63M | 1.54M | 1.91M | 1.25M | 543.85K | 2.07M | 2.12M | 1.69M | 719.73K | 508.27K | 1.24M | 869.08K | 1.53M | 1.47M | 1.44M | 1.72M | 1.53M | 1.25M | 1.22M | 1.28M | 1.31M | 1.06M | 753.56K | 1.52M | 1.52M | 1.27M | 1.50M | 1.20M | 687.73K | 831.82K | 518.07K | 721.87K | 1.03M | 1.11M | 949.13K | 610.92K | 695.45K | 215.07K | 642.45K |
| Net Income | 1.56M | 1.34M | 1.28M | 1.34M | 901.27K | 411.43K | 1.46M | 1.51M | 1.22M | 525.09K | 405.38K | 900.13K | 634.43K | 1.10M | 1.09M | 1.06M | 1.39M | 1.32M | 1.22M | 1.08M | 1.07M | 790.31K | 1.19M | 717.53K | 1.18M | 1.34M | 1.02M | 911.47K | 633.32K | 345.52K | 756.08K | 461.09K | 626.76K | 925.44K | 956.23K | 865.48K | 560.89K | 626.83K | 268.44K | 818.90K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.26 | - | - | 0.20 | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D Expense | 148.30K | 150.62K | 259.54K | 146.97K | 128.36K | 294.81K | 166.31K | 156.54K | 184.10K | 177.57K | 157.90K | 158.59K | 189.73K | 158.28K | 159.53K | 101.66K | 91.28K | 98.30K | 98.66K | 93.85K | 104.80K | 107.73K | 108.57K | 114.84K | 88.29K | 130.03K | 130.74K | 131.67K | 112.27K | 120.92K | 126.96K | 128.73K | 98.14K | 102.98K | 111.66K | 111.07K | 114.39K | 107.87K | 117.10K | 115.02K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.72M | 14.34M | 13.83M | 15.42M | 13.45M | 14.01M | 10.78M | 12.97M | 13.45M | 13.60K | 10.99M | 13.93M | 12.70M | 10.89M | 12.18M | 10.55M |
| Operating Income | 5.06M | 6.14M | 6.10M | 7.30M | 5.49M | 6.29M | 3.39M | 5.24M | 5.58M | 5.40M | 3.64M | 5.67M | 4.04M | 2.86M | 3.65M | 2.24M |
| Net Income | 3.80M | 4.72M | 4.83M | 5.90M | 4.05M | 4.61M | 2.58M | 3.84M | 4.35M | 4.76M | 3.30M | 4.66M | 2.57M | 2.58M | 3.25M | 2.11M |
| R&D Expense | - | 637.00K | 693.00K | 717.00K | 730.41K | 648.21K | 651.83K | 646.08K | 399.52K | 397.39K | 451.21K | 478.64K | 490.77K | 463.99K | 456.78K | 463.64K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 14.07M | 15.26M | 13.86M | 15.65M | 15.94M | 15.69M | 14.87M | 12.85M | 12.54M | 12.36M | 11.92M | 12.24M | 10.64M | 12.92M | 13.80M | 13.11M |
| Total Equity | 15.66M | 13.05M | 14.11M | 12.84M | 14.24M | 14.74M | 14.58M | 13.82M | 11.40M | 10.92M | 10.63M | 10.35M | 9.82M | 9.27M | 11.39M | 11.88M | 11.23M |
| Cash & Equivalents | 5.02M | 1.51M | 1.09M | 1.75M | 1.63M | 2.02M | 1.08M | 424.30K | 724.72K | 550.13K | 1.05M | 591.44K | 531.21K | 830.45K | 8.24M | 1.88M | 1.25M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.53M | 1.91M | 1.88M |
| Current Liabilities | - | 1.02M | 1.08M | 827.51K | 1.25M | 974.97K | 988.37K | 1.05M | 1.42M | 1.37M | 1.34M | 1.41M | 2.34M | 1.37M | 1.53M | 1.91M | 1.67M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.09M | 4.44M | 5.38M | 5.81M | - | - | 2.29M | 3.99M | 4.95M | 4.48M | 3.59M | 5.31M | 2.53M | 3.14M | 3.47M | 1.97M |
| Investing Cash Flow | 746.32K | -1.18M | 1.53M | -1.46M | - | - | 490.24K | 2.82M | -308.76K | 1.07M | -468.68K | -183.47K | 897.56K | 4.73M | -7.08M | 175.34K |
| Financing Cash Flow | -8.35M | -3.68M | -6.25M | -4.46M | - | - | -3.44M | -6.51M | -4.82M | -5.05M | -3.58M | -5.19M | -3.12M | -459.39K | -2.76M | -2.77M |
| Capital Expenditure | -454.55K | -274.64K | -252.36K | -288.37K | -54.59K | -62.57K | -166.69K | -38.15K | -74.99K | -113.77K | -43.40K | -116.38K | -75.18K | -165.72K | -433.08K | -58.99K |
| Free Cash Flow | 3.64M | 4.16M | 5.13M | 5.52M | - | - | 2.12M | 3.95M | 4.88M | 4.36M | 3.55M | 5.20M | 2.45M | 2.98M | 3.03M | 1.91M |
| Share Buybacks | 3.76M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 4.58M | 3.68M | 6.25M | 4.46M | 3.68M | 4.59M | 3.44M | 6.51M | 4.82M | 5.05M | 3.58M | 5.19M | 3.12M | 459.39K | 2.76M | 2.77M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 36.9% | 42.8% | 44.1% | 47.4% | 40.8% | 44.9% | 31.5% | 40.4% | 41.5% | 39,678.9% | 33.1% | 40.7% | 31.8% | 26.3% | 29.9% | 21.3% |
| Net Margin % | 27.7% | 32.9% | 34.9% | 38.3% | 30.1% | 32.9% | 24.0% | 29.6% | 32.4% | 35,014.9% | 30.1% | 33.4% | 20.2% | 23.7% | 26.7% | 20.0% |
| ROE % | 29.1% | 33.4% | 37.6% | 41.5% | 27.5% | 31.6% | 18.7% | 33.7% | 39.8% | 44.8% | 31.9% | 47.4% | 27.7% | 22.7% | 27.4% | 18.7% |
| ROCE % | 38.8% | 43.3% | 46.8% | 50.7% | 36.7% | 42.8% | 24.5% | 45.8% | 49.9% | 49.0% | 34.6% | 57.2% | 43.6% | 25.1% | 30.7% | 19.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Renaissance Technologies, LLC | 3.63% | 166.77K | $1.19M |
| 2 | Gamco Investors, Inc ET AL | 3.58% | 164.39K | $1.18M |
| 3 | Vanguard Capital Management LLC | 2.79% | 128.34K | $917.63K |
| 4 | Dimensional Fund Advisors LP | 1.59% | 73.17K | $523.16K |
| 5 | Rodgers Brothers Inc. | 1.30% | 59.60K | $426.14K |
| 6 | Teton Advisors, LLC | 1.17% | 53.76K | $384.39K |
| 7 | Parthenon LLC | 1.10% | 50.64K | $362.05K |
| 8 | Gabelli Funds, LLC | 0.83% | 38.00K | $271.70K |
| 9 | Geode Capital Management, LLC | 0.77% | 35.42K | $253.28K |
| 10 | United Capital Financial Advisors, LLC | 0.44% | 20.07K | $143.50K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UG
Guess Which Canadian Gold Stock Surpassed Its Drilling Expectations - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNVnNJRWFRb3h6RVk3UDR1NkxQT3ZsS0hEMmR2UkdxUFdoalc2T0JKX1dyY3lnWUM0ZmRmNnNMZU40MXVodUxZRm5wNlA0RTJ6Y2lESDU0TlNud1VZVlRFMmdJbXV6ejhYbkpXYnBQRXNHdVFOZlVFNEkxMTJBNnhOZXVudnMyVW40UDI4U1…
Precision Trading with United-guardian Inc. (UG) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQOU9uSnlwRDdIQzRRY1d4YzhsLS1MUlZ2akFsVTFrbmM3VG1WOGxDa0lyMXJjOG5EbHlhRElCM1pCTTR6SHVTNF80VXhhcU1vOEFvbXpaWmYxc1VwNWE0TDVCVENDSWlKSG8zd2JuMXN0b0lSR05CajhLZFdJNi1EVHQzUkIwd3pUeFNraH…
UG Q2 Earnings Rise Y/Y on Strong Cosmetic Ingredient Sales - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOWnFkQTlCdzhqLUdFMm5lSG5tc2tHSUM0a3Jpb0hZZnVoSkRGVl9PZjR4bjk2dW4xTHNHUW40UUxFbFFqS09vano3aUtvQUVmYTJ6RlVNS1QyWFdObGlXa3RqNWlqR0YwaHgxYnh4aEJUeExBZi1FcjVYSGlZMVUzUVhuWll6Y3ZSSnh5RE…
CN:UG Stock Today: Why Investors Are Watching UpSide Gold After Drilling Surpasses 4,645 Metres - kalkine.ca
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQOGY3QktzZmFRNm1IVU15SEM4dE1pWGZyek9nR0w3OTllc1UxcXcta28tSG5oTVVVZDhfTlVDZkJ0b2stVEtxcFlVejQtbkFmdDloa012eVU0aVFWV2o1VmlsM0tOVy0wWVpISUlNUm16N1oyeE03ekM0UkpsTU9XaGl5RDVtZmdfTzdDOX…
How Uganda’s stock market is making people rich - monitor.co.ug
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPV0FVVF9CcVNNOGF3N3lyZDNOeXgtQ1NSb2x6VmczQmwtS1hKdHh6MEhROHBkS3VoUEdEdEZFVGRJZjl3WkZMdFBmRmM3UkVOajJ1QmhDSElpZ0Vfb0F6cmFjdWZjOHdReXVUVThzaFM0NE1OX21fXzA5UlAwZG5MOWlOS1kzZzM3dXZqcm…
United-Guardian Marks 31 Years of Consecutive Dividends - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOMWcwU3U2eFMyaTFFTDN4Q0pFOGN4MGtaYWFRaDB0SDloQXdOMHowM1JnR0RQUTdwcXZpTEtKM0g4dFdvU2N5MnBLNFV4b0dVNWFrNllfY0hLWUZrSEVvaVQwXzlaNks2OHBZbG5nVEhWUElrMWZYU3N2eGdvWHM3VmlGSzFxSFdTb3c?oc…
UG — Frequently Asked Questions
What is the current share price of United-Guardian, Inc. (UG)?
As of 2026-09-07 16:24 PDT, United-Guardian, Inc. (UG) trades at $7.11 on NasdaqGM. Its 52-week range is $5.23 to $8.08.
What is the market capitalisation of UG?
United-Guardian, Inc. (UG) has a market capitalisation of $32.67M on NasdaqGM.
What is the P/E ratio of UG?
UG trades at a trailing price-to-earnings (P/E) ratio of 13.17. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is 2.98.
Does UG pay a dividend?
United-Guardian, Inc. (UG) currently offers a dividend yield of 7.88%.
What is the return on equity (ROE) of UG?
UG has a return on equity (ROE) of 18.75%. Its return on capital employed (ROCE) is 19.61%.
Is UG a good stock to buy?
This page provides a data-driven analysis of United-Guardian, Inc. (UG), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.